FDA Peptide Reclassification 2026: What It Means for Providers 2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche FDA takes first step in possible reversal of ban on some peptides The Washington Post The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be